NEXT Financial Group, Inc - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$10,000
-47.4%
5000.0%0.00%
-50.0%
Q2 2021$19,000
+46.2%
5000.0%0.00%
+100.0%
Q1 2021$13,000
+18.2%
5000.0%0.00%0.0%
Q4 2020$11,000
+22.2%
5000.0%0.00%0.0%
Q3 2020$9,0000.0%5000.0%0.00%0.0%
Q1 2020$9,000
-18.2%
5000.0%0.00%0.0%
Q4 2019$11,000
+57.1%
5000.0%0.00%0.0%
Q3 2019$7,0005000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$89,888,00013.40%
EcoR1 Capital, LLC 3,627,597$79,916,0007.20%
Aquilo Capital Management, LLC 614,436$13,536,0005.08%
RTW INVESTMENTS, LP 5,874,229$129,409,0004.88%
BRIDGER MANAGEMENT, LLC 1,981,633$43,655,0003.15%
ACUTA CAPITAL PARTNERS, LLC 387,500$8,537,0002.11%
Integral Health Asset Management, LLC 200,000$4,406,0001.72%
Burrage Capital Management LLC 104,047$2,292,0001.54%
Parkman Healthcare Partners LLC 240,000$5,287,0001.53%
EAM Global Investors LLC 122,237$2,693,0001.08%
View complete list of DICERNA PHARMACEUTICALS INC shareholders